News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clock Is Ticking For AstraZeneca PLC (AZN)


2/26/2014 8:13:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This morning Eli Lilly & Co . (LLY) released top-line results for the sixth AWARD study for their once-weekly GLP-1 dulaglutide. According to a company issued press release; “In the AWARD-6 study, once-weekly dulaglutide 1.5 mg achieved the primary endpoint of non-inferiority to once-daily liraglutide 1.8 mg, as measured by the reduction of hemoglobin A1c (HbA1c) from baseline at 26 weeks.”

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES